2. Signaling Pathways
  3. Immunology/Inflammation
  4. Interleukin Related
  5. Interleukin Related Agonist

Interleukin Related Agonist

Interleukin Related Isoform Comparison

Interleukin Related Agonists (5):

Cat. No. Product Name Effect Purity
  • HY-121488
    GP130 receptor agonist-1
    		Agonist 99.96%
    GP130 receptor agonist-1 is a potent, brain-penetrant and orally active GP130 receptor agonist. GP130 receptor agonist-1 has a neuroprotective effect on NMDA-induced neurotoxicity.
  • HY-101757
    NO-prednisolone
    		Agonist ≥99.0%
    NO-prednisolone is a nitric oxide (NO)-releasing derivative of Prednisolone. NO-prednisolone potently stimulates IL-10 production in vivo.
  • HY-156997
    ABX196
    		Agonist
    ABX196 is NKT agonist. ABX196 is an analog of the parental compound -GalCer.
  • HY-P991077
    Nogapendekin alfa inbakicept
    		Agonist
    Nogapendekin alfa inbakicept is a IL-15 superagonist that enhances anti-tumor immune responses by activating NK cells and T cells, and is being studied for the treatment of non-muscle-invasive bladder cancer (NMIBC).
  • HY-P99759
    Nogapendekin alfa (his tag)
    		Agonist
    Nogapendekin alfa (his tag), a soluble protein subunit of a human interleukin (IL)-15 variant, is a superagonist of IL-15. Nogapendekin alfa (his tag) promotes the proliferation and viability of immune cells. Nogapendekin alfa (his tag) combines with Inbakicept (HY-P99661) at a ratio of 2:1, to form N-803 (Nogapendekin alfa inbakicept), an IL-15 cytokine antibody fusion protein. N-803 reduces tumor burden by activation of NK cells and CD8+ T cells.